Merck to acquire Verona Pharma for $10 billion
Tweet
Share
E-mail
FILE PHOTO: Merck logo and decreasing stock graph are seen in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) -Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's presence in respiratory treatments as it readies for the patent expiry of its blockbuster cancer drug.
(Reporting by Christy Santhosh in Bengaluru; Editing by Sriraj Kalluvila)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) PT Raised to $170 at Guggenheim
- Modine plans to rebrand as Modexus Solutions after Gentherm merger
- Viking Holdings approves $1 billion share repurchase program
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
